General Information of Drug (ID: DM38F50)

Drug Name
PTX-35 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM38F50

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tumor necrosis factor receptor member 25 (TNFRSF25) TTDV6BQ TNR25_HUMAN Agonist [2]

References

1 ClinicalTrials.gov (NCT04430348) PTX-35 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Pelican Therapeutics.